GENFARMA was established on February 6, 2001. Its activity is centered in the manufacturing of lyophillized vials and liquid ampoules for itself and third parties. The laboratory belongs to the most important Spanish group (according to IMS 2009) of injectables for hospitals (GES Genéricos Españoles). The investment in this completely new manufacturing plant is of about 13 million euros.
The secondary activity of the company is the export of all the group’s products to the international markets under licence or under manufacturing contract.